Novartis Will Appeal European Committee Recommendation Against Zelnorm Approval
This article was originally published in The Pink Sheet Daily
Executive Summary
European Medicines Agency’s drug review committee agreed that tegaserod may not provide relief of irritable bowel syndrome in the standard setting.